hypothyroidism detected by neonatal screening programmes, about half the patients were started on treatment without the underlying anatomical abnormality being defined.5 1314 However at our centre each infant had been given his anatomical diagnosis before treatment was started. This has enabled us to determine more precisely the incidence of such abnormalities, and to characterise the clinical and laboratory features.
Methods
Each infant in this report was assessed at the time that neonatal hypothyroidism was detected and was then followed up at the Hospital for Sick Children, Toronto. Two methods of screening were used. Between October 1973 and December 1978 most infants were screened using an initial thyroxine (T4) screening test on cord blood and a supplementary thyrotrophin (TSH) on the lowest 10-15% of T4 results.3 4 Since January 1979 screening with an initial rapid TSH test'5 from cord blood serum (recall 50 ,U/ml) or dried cord blood spotted on filter paper (recall >25 ±U/ml) has been used.'6 A few infants who had been born outside metropolitan Toronto were detected by the Ontario screening programme which uses dried heel blood collected on filter paper at between age 3 and 5 days. In these infants heel blood was assayed initially for T4,17 and a secondary TSH screening test16 was performed on the lowest 10% of the blood T4 of each assay. Any infant with a TSH value > 100 ,d.U/ml on cord blood serum, or >50 ,U/ml on dried heel or cord blood was admitted to the Hospital for Sick Children for immediate investigation and treatment. Any infant with a TSH value of 50 to 100 ,uU/ml on cord blood serum, or 25 to 50 ,.U/ml on dried heel or cord blood was recalled for a repeat serum sample and was investigated only if repeat values showed a persistent increase in TSH for his age.
They were assessed clinically by history and complete physical examination to detect predisposing factors such as maternal diet, drug ingestion, parental consanguinity, or family history of thyroid disease or signs of hypothyroidism. At recall all infants had serum taken for repeat T4, triiodothyronine (T3), T3 resin uptake, and TSH. After a blood sample had been collected an x-ray film of the knees was taken to estimate skeletal maturation.'8 A low dose radioiodine uptake using 1 to 2 ,aCi of 131-I was obtained at 0200 and 2400 hours, and a scan employing 0 5 and 2-0 VtCi of technetium-99m with doses determined on the basis of surface area was performed to define the size, location, and activity of the thyroid gland except for any infant with an obvious diffuse goitre by palpation. TSH values were greater than 100 ,uU/ml in every infant found to have athyrosis or an ectopic thyroid gland. Seven of the 14 patients in the goitrous group had TSH values greater than 100 ,uU/ml. In 12 of these goitrous patients, the TSH value at recall was higher than it had been in the original screening test.
Skeletal maturation was delayed in 8 of 9 with athyrosis, in 6 of 11 infants with ectopy, and in 6 of 9 patients with goitres. Thus, in 7 of 30 infants with congenital hypothyroidism in whom bone age was group assessed, skeletal maturation was normal; this observation has been noted previously.3 4 The radioactive 131-I uptake was significantly higher in the goitrous group at both 0200 and 2400 hours (P<0-001, see Table 6 ). Although there was a difference in the mean values between the athyrotic and ectopic groups this was not significant. Eight of the athyrotic patients had normal uptakes at 0200 hours, but all were abnormally low at 2400 hours. Results of the 131-I uptakes at both 0200 and 2400 hours overlapped greatly (Table 6 ). Although these results were of some help in the goitrous patients they did not differentiate between patients with athyrosis and those with an ectopic gland. Furthermore, the tests delayed the start of treatment and added an extra burden of radiation to the patients. In contrast, the technetium scan was very reliable in differentiating between the three groups of patients; it gave a rapid diagnosis, thereby enabling treatment with T4 to be started even before the repeat serum T4 and TSH values became available. Only in patients in whom a thyroid scintiscan was of normal location and size was it necessary to await the repeat serum results before beginning treatment to rule out transient hypothyroidism. 19 We now no longer routinely perform radioactive 13L1-1 uptakes but instead rely on a technetium scan (or preferably a 123.1 scan) to classify our patients.
Since January 1979 the age at which treatment began has been greatly reduced. This is partly because the screening system is now more efficient but it is also due to the use of primary TSH estimations in cord blood which was initiated in January 1979 
